Compare BIO & MTDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BIO | MTDR |
|---|---|---|
| Founded | 1952 | 2003 |
| Country | United States | United States |
| Employees | 7450 | 483 |
| Industry | Biotechnology: Laboratory Analytical Instruments | Oil & Gas Production |
| Sector | Industrials | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 7.3B |
| IPO Year | N/A | 2011 |
| Metric | BIO | MTDR |
|---|---|---|
| Price | $262.97 | $58.48 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 15 |
| Target Price | ★ $358.50 | $60.93 |
| AVG Volume (30 Days) | 235.7K | ★ 1.9M |
| Earning Date | 04-30-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 2.63% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 6.09 |
| Revenue | N/A | ★ $3,696,277,000.00 |
| Revenue This Year | $2.74 | N/A |
| Revenue Next Year | $3.05 | $10.58 |
| P/E Ratio | $9.72 | ★ $9.37 |
| Revenue Growth | N/A | ★ 5.46 |
| 52 Week Low | $211.43 | $35.19 |
| 52 Week High | $343.12 | $58.51 |
| Indicator | BIO | MTDR |
|---|---|---|
| Relative Strength Index (RSI) | 40.24 | 69.38 |
| Support Level | $239.33 | $41.12 |
| Resistance Level | $289.61 | N/A |
| Average True Range (ATR) | 7.46 | 1.92 |
| MACD | 0.44 | 0.01 |
| Stochastic Oscillator | 19.99 | 85.77 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Matador Resources Co is an independent energy company engaged in the exploration, development, production, and acquisition of oil and natural gas resources. The majority of the company's assets are located in the United States, with an emphasis on oil and natural gas shale and other unconventional plays. Along with maintaining a portfolio of oil and natural gas properties, Matador works to identify and develop midstream opportunities that support and enhance its exploration and development business. The Company has two reportable business segments: exploration and production and midstream. The company generates majority of its revenue from the exploration and production segment.